193 related articles for article (PubMed ID: 25005357)
1. Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors.
Foronjy RF; Taggart CC; Dabo AJ; Weldon S; Cummins N; Geraghty P
Mucosal Immunol; 2015 Jan; 8(1):161-75. PubMed ID: 25005357
[TBL] [Abstract][Full Text] [Related]
2. Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection.
Foronjy RF; Dabo AJ; Cummins N; Geraghty P
BMC Immunol; 2014 Oct; 15():41. PubMed ID: 25277705
[TBL] [Abstract][Full Text] [Related]
3. Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons.
Makris S; Bajorek M; Culley FJ; Goritzka M; Johansson C
J Innate Immun; 2016; 8(5):452-63. PubMed ID: 27423203
[TBL] [Abstract][Full Text] [Related]
4. Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.
Guo X; Liu T; Shi H; Wang J; Ji P; Wang H; Hou Y; Tan RX; Li E
J Virol; 2015 Aug; 89(15):7636-45. PubMed ID: 25972545
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits the TRIF-dependent pathway by upregulating sterile alpha and armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection.
Liu T; Zang N; Zhou N; Li W; Xie X; Deng Y; Ren L; Long X; Li S; Zhou L; Zhao X; Tu W; Wang L; Tan B; Liu E
J Virol; 2014 Apr; 88(8):4229-36. PubMed ID: 24478430
[TBL] [Abstract][Full Text] [Related]
6. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes.
Goritzka M; Makris S; Kausar F; Durant LR; Pereira C; Kumagai Y; Culley FJ; Mack M; Akira S; Johansson C
J Exp Med; 2015 May; 212(5):699-714. PubMed ID: 25897172
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-I{middle dot}NF- kappa B-inducing kinase signaling pathway.
Liu P; Li K; Garofalo RP; Brasier AR
J Biol Chem; 2008 Aug; 283(34):23169-78. PubMed ID: 18550535
[TBL] [Abstract][Full Text] [Related]
8. T cell responses are elicited against Respiratory Syncytial Virus in the absence of signalling through TLRs, RLRs and IL-1R/IL-18R.
Goritzka M; Pereira C; Makris S; Durant LR; Johansson C
Sci Rep; 2015 Dec; 5():18533. PubMed ID: 26688048
[TBL] [Abstract][Full Text] [Related]
9. MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus.
Bhoj VG; Sun Q; Bhoj EJ; Somers C; Chen X; Torres JP; Mejias A; Gomez AM; Jafri H; Ramilo O; Chen ZJ
Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14046-51. PubMed ID: 18780793
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.
Zang N; Xie X; Deng Y; Wu S; Wang L; Peng C; Li S; Ni K; Luo Y; Liu E
J Virol; 2011 Dec; 85(24):13061-8. PubMed ID: 21937650
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection.
Boyapalle S; Wong T; Garay J; Teng M; San Juan-Vergara H; Mohapatra S; Mohapatra S
PLoS One; 2012; 7(2):e29386. PubMed ID: 22383950
[TBL] [Abstract][Full Text] [Related]
12. MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice.
Long X; Li S; Xie J; Li W; Zang N; Ren L; Deng Y; Xie X; Wang L; Fu Z; Liu E
Respir Res; 2015 Feb; 16(1):11. PubMed ID: 25652021
[TBL] [Abstract][Full Text] [Related]
13. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
[TBL] [Abstract][Full Text] [Related]
14. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS.
Lifland AW; Jung J; Alonas E; Zurla C; Crowe JE; Santangelo PJ
J Virol; 2012 Aug; 86(15):8245-58. PubMed ID: 22623778
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
Pythoud C; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
J Virol; 2015 Jun; 89(12):6240-50. PubMed ID: 25833049
[TBL] [Abstract][Full Text] [Related]
16. Type I interferons and MAVS signaling are necessary for tissue resident memory CD8+ T cell responses to RSV infection.
Varese A; Nakawesi J; Farias A; Kirsebom FCM; Paulsen M; Nuriev R; Johansson C
PLoS Pathog; 2022 Feb; 18(2):e1010272. PubMed ID: 35108347
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil recruitment and activation are differentially dependent on MyD88/TRIF and MAVS signaling during RSV infection.
Kirsebom FCM; Kausar F; Nuriev R; Makris S; Johansson C
Mucosal Immunol; 2019 Sep; 12(5):1244-1255. PubMed ID: 31358860
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.
Liu P; Jamaluddin M; Li K; Garofalo RP; Casola A; Brasier AR
J Virol; 2007 Feb; 81(3):1401-11. PubMed ID: 17108032
[TBL] [Abstract][Full Text] [Related]
19. The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation.
Webster Marketon JI; Corry J; Teng MN
Virology; 2014 Jan; 449():62-9. PubMed ID: 24418538
[TBL] [Abstract][Full Text] [Related]
20. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection.
Lee HC; Headley MB; Loo YM; Berlin A; Gale M; Debley JS; Lukacs NW; Ziegler SF
J Allergy Clin Immunol; 2012 Nov; 130(5):1187-1196.e5. PubMed ID: 22981788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
